Lyme disease: Novel investigative oral therapeutic trials show positive topline results
by Press Release from Outbreak News Today on (#66WWN)
NewsDesk @bactiman63 Tarsus Pharmaceuticals, Inc. announced positive topline results from the completed Phase 1b Callisto trial and the enrollment of the first subject in the Carpo Phase 2a trial. The Callisto and Carpo trials are designed to evaluate TP-05, a novel investigative oral therapeutic for the potential prevention of Lyme disease. The Callisto trial was a [...]
The post Lyme disease: Novel investigative oral therapeutic trials show positive topline results appeared first on Outbreak News Today.